Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Totelle for Vasomotor Symptoms in Postmenopausal Women
NCT00195455Phase 4Completed
- Sponsor
- Pfizer
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of trimegestone in vasomotor symptoms, sponsored by Pfizer. Primary endpoint: Vasomotor Symptoms Control. Started Feb 2005; status: completed.
02
Drugs
trimegestone
03
Conditions
vasomotor symptoms
Beyond the preview
Go deeper on NCT00195455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00195455.